Holdings
Roundhill GLP-1 & Weight Loss ETF
As of Jun 30, 2026, Roundhill GLP-1 & Weight Loss ETF reported 23 positions worth US$52.2M. Largest: Novo Nordisk A/S Class B, Eli Lilly and Company and Pfizer, Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 23
- Value as reported
- US$52.2M
- Holdings as of
- Jun 30, 2026
- Last filed
- Aug 26, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Novo Nordisk A/S Class B OMXCOP:NOVO_B | 148K | US$7.01M | 13.0% | −31,495 | Jun 30, 2026 |
| Eli Lilly and Company NYSE:LLY | 5,722 | US$6.86M | 12.7% | −3,281 | Jun 30, 2026 |
| Pfizer, Inc. NYSE:PFE | 143K | US$3.45M | 6.4% | +4,970 | Jun 30, 2026 |
| Kailera Therapeutics, Inc. NASDAQ:KLRA | 153K | US$3.36M | 6.2% | New | Jun 30, 2026 |
| Viking Therapeutics, Inc. NASDAQ:VKTX | 81,186 | US$3.17M | 5.9% | −2,383 | Jun 30, 2026 |
| CSPC Pharmaceutical Group Limited HKEX:1093 | 3.24M | US$2.88M | 5.3% | +1.94M | Jun 30, 2026 |
| Chugai Pharmaceutical Co., Ltd. TSE:4519 | 52,600 | US$2.44M | 4.5% | +19,800 | Jun 30, 2026 |
| Ascletis Pharma, Inc. HKEX:1672 | 1.69M | US$2.27M | 4.2% | +553K | Jun 30, 2026 |
| Zealand Pharma A/S OMXCOP:ZEAL | 47,873 | US$2.12M | 3.9% | +7,188 | Jun 30, 2026 |
| Amgen Inc. NASDAQ:AMGN | 5,750 | US$2.08M | 3.9% | −12 | Jun 30, 2026 |
| AstraZeneca PLC LSE:AZN | 10,931 | US$2.07M | 3.8% | +1,112 | Jun 30, 2026 |
| Hanmi Pharmaceutical Co., Ltd. KRX:128940 | 7,386 | US$1.9M | 3.5% | +1,793 | Jun 30, 2026 |
| Roche Holding Ltd SIX:RO | 3,972 | US$1.64M | 3.0% | −1,174 | Jun 30, 2026 |
| MBX Biosciences, Inc. NASDAQ:MBX | 27,421 | US$1.51M | 2.8% | −6,843 | Jun 30, 2026 |
| United Laboratories International Holdings Ltd. HKEX:3933 | 1.32M | US$1.42M | 2.6% | +368K | Jun 30, 2026 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A SSE:600276 | 182K | US$1.4M | 2.6% | New | Jun 30, 2026 |
| Hansoh Pharmaceutical Group Company Limited HKEX:3692 | 364K | US$1.37M | 2.5% | New | Jun 30, 2026 |
| Innovent Biologics, Inc. HKEX:1801 | 126K | US$1.28M | 2.4% | −117K | Jun 30, 2026 |
| Gubra A/S OMXCOP:GUBRA | 20,597 | US$1.01M | 1.9% | −2,126 | Jun 30, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 7,425 | US$938K | 1.7% | +382 | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM | 7,966 | US$884K | 1.6% | −497 | Jun 30, 2026 |
| Shionogi & Co., Ltd. TSE:4507 | 39,100 | US$671K | 1.2% | +6,400 | Jun 30, 2026 |
| Wave Life Sciences Ltd. NASDAQ:WVE | 80,432 | US$467K | 0.86% | +47,654 | Jun 30, 2026 |